{"id":"W2094364524","doi":"10.1185/03007995.2014.973939","title":"A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Liraglutide; Metformin; Type 2 diabetes; Clinical endpoint; Exenatide; Glycemic; Clinical trial; Internal medicine; Glucagon-like peptide 1 receptor; Hypoglycemia; Diabetes mellitus; Endocrinology; Insulin; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003946953,0.000231334,0.001610811,0.0002751878,0.00007086419,0.000009213211,0.0002617426,0.0001506213,0.0000533222],"category_scores_gemma":[0.005835933,0.0001255079,0.0002006698,0.0005357913,0.0006354122,0.00002451435,0.0006575783,0.0007359631,0.000009446437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000153753,"about_ca_system_score_gemma":0.0003583111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000116841,"about_ca_topic_score_gemma":0.000005153116,"domain_scores_codex":[0.9961236,0.0007901994,0.0007681858,0.0003572027,0.001543242,0.000417583],"domain_scores_gemma":[0.9972773,0.001546806,0.0002604893,0.0003603327,0.0003387078,0.0002164153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003722714,0.0004016421,0.001260452,0.05747295,0.0002486223,5.944239e-7,0.0001039447,2.873912e-8,0.000004630892,0.0001219137,0.001853134,0.9384949],"study_design_scores_gemma":[0.001191535,0.00116898,0.0008196466,0.1122152,0.000189772,4.194837e-7,0.00004639499,0.0001337247,0.00004117243,0.0001357791,0.8839303,0.0001271224],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004053336,0.9932869,0.000001653977,0.0002487885,0.0007422311,0.001559335,0.00001866337,0.000007627078,0.00008148627],"genre_scores_gemma":[0.001341472,0.9980162,0.00006966474,0.000009298185,0.0001990141,0.0001357907,0.0001678185,0.00001708879,0.00004361658],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9383677,"threshold_uncertainty_score":0.6986578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2948600957030492,"score_gpt":0.5409420813016502,"score_spread":0.2460819855986011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}